Oestrogen therapy for urinary incontinence in post-menopausal women.

The investigation and treatment of female pelvic floor dysfunction. Dtsch Arztebl Int (2015) 3.12

Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol (2014) 1.17

The Recent Review of the Genitourinary Syndrome of Menopause. J Menopausal Med (2015) 1.13

Pharmacotherapy of overactive bladder in adults: a review of efficacy, tolerability, and quality of life. Res Rep Urol (2013) 1.06

Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric (2015) 0.95

Postmenopausal hormone therapy: risks and benefits. Nat Rev Endocrinol (2013) 0.93

Mixed urinary incontinence: international urogynecological association research and development committee opinion. Int Urogynecol J (2014) 0.81

Prevention and management of pelvic organ prolapse. F1000Prime Rep (2014) 0.79

Impact of menopausal status on the outcome of pelvic floor physiotherapy in women with urinary incontinence. Int Urogynecol J (2013) 0.78

Local Oestrogen for Pelvic Floor Disorders: A Systematic Review. PLoS One (2015) 0.76

Postmenopausal overactive bladder. Prz Menopauzalny (2014) 0.76

Combined Tolterodine and Vaginal Estradiol Cream for Overactive Bladder Symptoms After Randomized Single-Therapy Treatment. Female Pelvic Med Reconstr Surg (2016) 0.75

Relationship between lower limb position and pelvic floor muscle surface electromyography activity in menopausal women: a prospective observational study. Clin Interv Aging (2017) 0.75

Positive association of female overactive bladder symptoms and estrogen deprivation: A nationwide population-based cohort study in Taiwan. Medicine (Baltimore) (2016) 0.75

Association of 17-β Estradiol with Adipose-Derived Stem Cells: New Strategy to Produce Functional Myogenic Differentiated Cells with a Nano-Scaffold for Tissue Engineering. PLoS One (2016) 0.75

Lower urinary tract symptoms after subtotal versus total abdominal hysterectomy: exploratory analyses from a randomized clinical trial with a 14-year follow-up. Int Urogynecol J (2015) 0.75

Functional outcomes of adjustable continence therapy (ACT™) balloons in women aged >80 years and suffering from stress urinary incontinence caused by intrinsic sphincter deficiency. World J Urol (2015) 0.75

Hormonal contraception and pelvic floor function: a systematic review. Int Urogynecol J (2015) 0.75

Factors associated with urinary incontinence in middle-aged women: a population-based household survey. Int Urogynecol J (2016) 0.75

Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev (2009) 1.63

A double-blind placebo-controlled trial on the effects of 25 mg estradiol implants on the urge syndrome in postmenopausal women. Int Urogynecol J Pelvic Floor Dysfunct (2003) 1.16

The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments. Trials (2011) 1.09

An evidence-based approach to lifestyle interventions in urogynaecology. Menopause Int (2007) 0.77

Obesity and urinary incontinence. Menopause Int (2008) 0.75

Field trial to determine the impact of providing additional care to litters on weaning weight of pigs. Can J Vet Res (2008) 0.75

Which procedure for incontinence? J Br Menopause Soc (2005) 0.75

Applying Regenerative Medicine to Battlefield Injuries. N C Med J (2016) 0.75

Using data collected for production or economic purposes to research production animal welfare: an epidemiological approach. J Appl Anim Welf Sci (2009) 0.75